The global medical imaging outsourcing market size was USD 8.70 billion in 2023, estimated at USD 9.07 billion in 2024 and is anticipated to reach around USD 13.78 billion by 2034, expanding at a CAGR of 4% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Medical Imaging Outsourcing Industry Impact
5.2. Medical Imaging Outsourcing Business Impact Assessment: Covid-19
5.2.1. Industry Challenges/Disruption
5.2.2. Market Trends and Medical Imaging Outsourcing Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Medical Imaging Outsourcing Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Demand for Advanced Medical Imaging Products
6.1.1.2. Technological Advancements in the Imaging Services
6.1.2. Market Restraints
6.1.2.1. Shortage of Skilled Radiologist
6.1.3. Market Opportunities
6.1.3.1. Significant Demand of Medical Imaging Outsourcing from Automotive Industry
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Medical Imaging Outsourcing Market Revenue by Market Player
7.1.1.2. Medical Imaging Outsourcing Market Revenue Market Share by Market Player
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geography Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Imaging Outsourcing Market, by Device, 2024-2034
8.1.1. Computed Tomography (CT)
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Positron Emission Tomography (PET)
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Magnetic Resonance Imaging (MRI)
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Overview and Regional Trends
9.1.2. Market Revenue Forecast by Device (2021-2034)
9.1.3. U.S
9.1.3.1. Market Revenue Forecast (2021-2034)
9.1.4. Canada
9.1.4.1. Market Revenue Forecast (2021-2034)
9.2. Europe
9.2.1. Overview and Regional Trends
9.2.2. Market Revenue Forecast by Device (2021-2034)
9.2.3. UK
9.2.3.1. Market Revenue Forecast (2021-2034)
9.2.4. Germany
9.2.4.1. Market Revenue Forecast (2021-2034)
9.2.5. France
9.2.5.1. Market Revenue Forecast (2021-2034)
9.2.6. Rest of EU
9.2.6.1. Market Revenue Forecast (2021-2034)
9.3. Asia Pacific (APAC)
9.3.1. Overview and Regional Trends
9.3.2. Market Revenue Forecast by Device (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue Forecast (2021-2034)
9.3.4. India
9.3.4.1. Market Revenue Forecast (2021-2034)
9.3.5. Japan
9.3.5.1. Market Revenue Forecast (2021-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue Forecast (2021-2034)
9.4. LATAM
9.4.1. Overview and Regional Trends
9.4.2. Market Revenue Forecast by Device (2021-2034)
9.4.3. Brazil
9.4.3.1. Market Revenue Forecast (2021-2034)
9.4.4. Rest of LATAM
9.4.4.1. Market Revenue Forecast (2021-2034)
9.5. Middle East and Africa (MEA)
9.5.1. Overview and Regional Trends
9.5.2. Market Revenue Forecast by Device (2021-2034)
9.5.3. GCC
9.5.3.1. Market Revenue Forecast (2021-2034)
9.5.4. North Africa
9.5.4.1. Market Revenue Forecast (2021-2034)
9.5.5. South Africa
9.5.5.1. Market Revenue Forecast (2021-2034)
9.5.6. Rest of MEA
9.5.6.1. Market Revenue Forecast (2021-2034)
10.1. Flatworld Solutions Pvt. Ltd.
10.1.1. Company Overview, Business Information, Regional Presence
10.1.2. Product Portfolio Analysis
10.1.2.1. Product Details, Specification, Application
10.1.3. Revenue, and Gross Margin
10.1.4. Recent Developments and Strategies
10.2. Alliance Medical
10.2.1. Company Overview, Business Information, Regional Presence
10.2.2. Product Portfolio Analysis
10.2.2.1. Product Details, Specification, Application
10.2.3. Revenue, and Gross Margin
10.2.4. Recent Developments and Strategies
10.3. MetaMed
10.3.1. Company Overview, Business Information, Regional Presence
10.3.2. Product Portfolio Analysis
10.3.2.1. Product Details, Specification, Application
10.3.3. Revenue, and Gross Margin
10.3.4. Recent Developments and Strategies
10.4. Diagnostic Imaging Services
10.4.1. Company Overview, Business Information, Regional Presence
10.4.2. Product Portfolio Analysis
10.4.2.1. Product Details, Specification, Application
10.4.3. Revenue, and Gross Margin
10.4.4. Recent Developments and Strategies
10.5. NORTH AMERICAN SCIENCE ASSOCIATES INC.
10.5.1. Company Overview, Business Information, Regional Presence
10.5.2. Product Portfolio Analysis
10.5.2.1. Product Details, Specification, Application
10.5.3. Revenue, and Gross Margin
10.5.4. Recent Developments and Strategies
10.6. Ankarad Medical Imaging Systems
10.6.1. Company Overview, Business Information, Regional Presence
10.6.2. Product Portfolio Analysis
10.6.2.1. Product Details, Specification, Application
10.6.3. Revenue, and Gross Margin
10.6.4. Recent Developments and Strategies
10.7. Shields MRI
10.7.1. Company Overview, Business Information, Regional Presence
10.7.2. Product Portfolio Analysis
10.7.2.1. Product Details, Specification, Application
10.7.3. Revenue, and Gross Margin
10.7.4. Recent Developments and Strategies
10.8. KAYI Healthcare
10.8.1. Company Overview, Business Information, Regional Presence
10.8.2. Product Portfolio Analysis
10.8.2.1. Product Details, Specification, Application
10.8.3. Revenue, and Gross Margin
10.8.4. Recent Developments and Strategies
10.9. RadNet, Inc.
10.9.1. Company Overview, Business Information, Regional Presence
10.9.2. Product Portfolio Analysis
10.9.2.1. Product Details, Specification, Application
10.9.3. Revenue, and Gross Margin
10.9.4. Recent Developments and Strategies
10.10. PROSCAN IMAGING
10.10.1. Company Overview, Business Information, Regional Presence
10.10.2. Product Portfolio Analysis
10.10.2.1. Product Details, Specification, Application
10.10.3. Revenue, and Gross Margin
10.10.4. Recent Developments and Strategies
11.1. About Us
11.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client